1. Home
  2. CHRO
  3. CHRO News

Latest Chromocell Therapeutics Corporation (CHRO) News on January 19, 2025

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine
CHRO

GlobeNewswire

a month ago

Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model
CHRO

GlobeNewswire

a month ago

Channel Therapeutics Announces Positive Efficacy Data For a Depot Formulation of a NaV1.7 Inhibitor in a Preclinical In Vivo Nerve Block Model

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates
CHRO

GlobeNewswire

2 months ago

Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
CHRO

GlobeNewswire

3 months ago

Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain

Chromocell to Present at Upcoming Fall Investor Conferences
CHRO

GlobeNewswire

3 months ago

Chromocell to Present at Upcoming Fall Investor Conferences

Chromocell Announces Amendment to Stock Repurchase Plan
CHRO

GlobeNewswire

3 months ago

Chromocell Announces Amendment to Stock Repurchase Plan

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
CHRO

GlobeNewswire

4 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum Agenda Announced for September 19th
CHRO

GlobeNewswire

4 months ago

Life Sciences Virtual Investor Forum Agenda Announced for September 19th

Chromocell to Participate in Life Sciences Investor Forum September 19th
CHRO

GlobeNewswire

4 months ago

Chromocell to Participate in Life Sciences Investor Forum September 19th

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
CHRO

GlobeNewswire

5 months ago

Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Chromocell Announces Stock Repurchase Plan
CHRO

GlobeNewswire

5 months ago

Chromocell Announces Stock Repurchase Plan

Chromocell to Participate in the Virtual Investor Lunch Break Series
CHRO

GlobeNewswire

6 months ago

Chromocell to Participate in the Virtual Investor Lunch Break Series

Edge Total Intelligence Inc. Updates Status of MCTO
CHRO

Newsfile

7 months ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
CHRO

CNW Group

7 months ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
CHRO

GlobeNewswire

7 months ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
CHRO

GlobeNewswire

7 months ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
CHRO

GlobeNewswire

7 months ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
CHRO

GlobeNewswire

7 months ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
CHRO

CNW Group

7 months ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
CHRO

PR Newswire

7 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
CHRO

GlobeNewswire

8 months ago

Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024

Chromocell Issues Letter to Stockholders from Chief Executive Officer
CHRO

GlobeNewswire

9 months ago

Chromocell Issues Letter to Stockholders from Chief Executive Officer

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
CHRO

GlobeNewswire

10 months ago

Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
CHRO

GlobeNewswire

10 months ago

Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023

Sidoti Events, LLC's Virtual March Small-Cap Conference
CHRO

ACCESSWIRE

10 months ago

Sidoti Events, LLC's Virtual March Small-Cap Conference

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
CHRO

GlobeNewswire

10 months ago

Chromocell to Present at Sidoti Virtual Investor Conference March 13-14

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
CHRO

GlobeNewswire

a year ago

Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
CHRO

GlobeNewswire

a year ago

Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
CHRO

GlobeNewswire

a year ago

Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering

Share on Social Networks: